Concepedia

Author

P.H.M. de Mulder

Radboud University Nijmegen

Also Known As

G Kaiser, P H De Mulder, P H M De Mulder, P H M de Mulder, P H MULDER, P H de Mulder, P. H. M. DE MULDER, P. H. M. De Mulder, P. H. M. Mulder, P. H. M. de Mulder

176

Publications

5.6K

Citations

34

H-Index

78

Concepts

All Affiliations

Radboud University NijmegenRadboud University Medical CenterRotterdam University of Applied SciencesEuropean Organisation for Research and Treatment of CancerNorwegian Cancer Society
PD

About

P.H.M. de Mulder is an author at Radboud University Nijmegen specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

33

1.2K

2

Health Sciences

5

5

98

3

Education

2

2

57

4

Engineering

1

1

54

5

Natural Sciences

1

1

10

P.H.M. de Mulder

×

63

Publications

3.8K

Citations

29

H-Index

YearCitations

Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

Cora N. Sternberg, P.H.M. de Mulder, Jan H. Schornagel,

Journal of Clinical Oncology

2001

624

Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council

Ronald de Wit, J.T. Roberts, P M Wilkinson,

Journal of Clinical Oncology

2001

361

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

S. Krege, J. Beyer, Rainer Souchon,

European Urology

2008

252

Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting

P.H.M. de Mulder

Annals of Internal Medicine

1990

232

E‐cadherin expression in head and neck squamous‐cell carcinoma is associated with clinical outcome

Vera Mattijssen, P.H.M. de Mulder, H. M. Peters,

International Journal of Cancer

1993

172

Quality of Life in Good Prognosis Patients With Metastatic Germ Cell Cancer: A Prospective Study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)

Sophie D. Fosså, Ronald de Wit, J.T. Roberts,

Journal of Clinical Oncology

2003

131

Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer

A.S.T. Planting, G. Catimel, P.H.M. de Mulder,

Annals of Oncology

1999

97

Randomized Phase II/III Trial of Interferon Alfa-2a With and Without 13-<i>cis</i>-Retinoic Acid in Patients With Progressive Metastatic Renal Cell Carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)

Nina Aass, P.H.M. de Mulder, G. Mickisch,

Journal of Clinical Oncology

2005

97

Intratumoral Recombinant Human Interleukin-12 Administration in Head and Neck Squamous Cell Carcinoma Patients Modifies Locoregional Lymph Node Architecture and Induces Natural Killer Cell Infiltration in the Primary Tumor

Carla M.L. van Herpen, Jeroen van der Laak, I. Jolanda M. de Vries,

Clinical Cancer Research

2005

93

Intratumoral rhIL‐12 administration in head and neck squamous cell carcinoma patients induces B cell activation

Carla M.L. van Herpen, Robbert van der Voort, Jeroen van der Laak,

International Journal of Cancer

2008

88

Page 1